Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB161811

Creatine Kinase BB Antibody (8E4), DyLight 650, Novus Biologicals™
SDP

Catalog No. NB161811 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB161811 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. NB161811 Supplier Novus Biologicals Supplier No. NBP259462C
Add to Cart
Add to Cart
This item is not returnable. View return policy

Description

Mouse Monoclonal Antibody

Creatine Kinase BB Monoclonal antibody specifically detects Creatine Kinase BB in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunofluorescence

Specifications

Antigen Creatine Kinase BB
Applications Western Blot, Flow Cytometry, ELISA, Immunofluorescence
Classification Monoclonal
Clone 80000
Conjugate DyLight 650
Formulation 50mM Sodium Borate
Gene Alias Creatine Kinase Isoenzyme
Host Species Mouse
Immunogen Recombinant human Creatine Kinase BB (1-381aa) purified from E. coli
Purification Method Protein A purified
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Cancer
Primary or Secondary Primary
Gene ID (Entrez) 1152
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2a κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.